1 / 8

Need for Higher Drug Efficacy to Drive Global Companion Diagnostics Market to US$5.6 Bn by 2019

In a recent market study from Transparency Market Research (TMR), the global companion diagnostics market is estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013. This growth amounts to a remarkable CAGR of 18.1% from 2013 to 2019.

priyap01
Download Presentation

Need for Higher Drug Efficacy to Drive Global Companion Diagnostics Market to US$5.6 Bn by 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Need for Higher Drug Efficacy to Drive Global Companion Diagnostics Market to US$5.6 Bn by 2019 Published Date Page Report 29-Aug-2013 Request Sample Buy Now Press Release http://www.transparencymarketresearch.com/pressrelease/companion-diagnostics-market.htm Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Breast Pumps Market REPORT DESCRIPTION Companion Diagnostics Market is expected to reach $5.6 billion by 2019, growing at a compound annual growth rate (CAGR) of 18.1% during the period In a recent market study from Transparency Market Research (TMR), the global companion diagnostics market is estimated to reach US$5.6 billion by 2019, increasing from US$1.8 billion in 2013. This growth amounts to a remarkable CAGR of 18.1% from 2013 to 2019.The report, titled “Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, is available for sale on the company website.Companion diagnostics enable physicians to make more precise decisions for specific drug treatments depending on the patient’s response at every stage of the course of treatment. The tests indicate both favorable and adverse reactions to a certain line of treatment and also help optimize drug dosage. Companion diagnostics refer to tests or procedures which help physicians in making improved treatment decisions regarding patients depending on their response to ongoing treatments. The rising demand for personalized medicine has largely driven the global companion diagnostics market. The market research report offers apt insights on the industry, tracking its growth, development and success during the forecast period of 2013 to 2019. The scope and dynamics of the market are covered in the report and the overall industry is segmented on the basis of tests for various indications and geographical location. Potential growth opportunities, emerging sectors, market drivers, challenges, landmarks, trends, government regulations and competitive landscape are also highlighted in the research report. In addition, the study discusses the value chain as well as Porter’s five forces analysis, highlighting the impact of suppliers, buyers, substitutes, new entrants and competitors on the global market. Enquiry before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387 Overview of the companion diagnostics market 2 Transparency Market Research

  3. Breast Pumps Market The worldwide market for companion diagnostics was worth $1.8 billion in 2012 and is expected to reach $5.6 billion by 2019, growing at a compound annual growth rate (CAGR) of 18.1% during the period. The mounting R&D efforts in the field of diagnostics, advances in technologies, increasing focus on targeted therapies, and the constant attempts on the part of pharmaceutical manufacturers to lower the cost of drugs development has greatly benefited the industry. Moreover, favorable regularity changes on the part of governments, and the focus of pharmaceutical companies on in-house development of companion diagnostics or collaborating with diagnostics firms for the same are expected to further propel the market. On the other hand, the factors which hamper the growth, as identified by the research report, are unfavorable reimbursement scenario, lengthy phases of development and approval of diagnostic technologies, and the rising influence of clinical societies and advocacy groups. The global companion diagnostics market was led by North America in 2012, contributing more than 35% of the total revenue share. The major driving forces in the North American regional markets include widening consumer base owing to rising number of cancer cases, rising awareness regarding personalized healthcare, increased affordability of expensive procedures, and high-quality medical equipment and technology available. Increasing healthcare infrastructure and greater acceptance of innovative medical procedures will boost the regional markets in Asia and Latin America. Browse Full Press Release @ http://www.transparencymarketresearch.com/pressrelease/companion-diagnostics-market.htm TABLE OF CONTENT Table of contents Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.4 List of Abbreviations 3 Transparency Market Research

  4. Breast Pumps Market Chapter 2 Executive Summary Chapter 3 Market Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Regulatory changes: The need for development of CDx along with targeted therapies 3.2.2 Increasing demand as well as developmental efforts towards personalized medicine 3.2.3 The pharmacoeconomic advantage: Reduced drug development costs 3.2.4 Increasing cancer incidence worldwide 3.2.5 Impact Analysis of Market Drivers 3.3 Market Restraints 3.3.1 Effect of influence of advocacy groups and clinical societies 3.3.2 Prolonged developmental and approval phases 3.3.3 Reimbursement scenario 3.3.4 Impact Analysis of Market Restraints 3.4 Market Opportunity 3.4.1 Expansion into newer indication areas 3.5 Porter’s Five Forces Analysis: Global Companion Diagnostics Market 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012 Chapter 4 Companion Diagnostics Market, by Indication, 2011 - 2019 (USD Million) 4.1 Introduction 4.1.1 Comparative Analysis: Global Companion Diagnostics Market, by Indication, 2012 & 2019 (Value %) 4.1.2 Breast Cancer 4 Transparency Market Research

  5. Breast Pumps Market 4.1.2.1 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.3 Lung Cancer 4.1.3.1 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.4 Colorectal Cancer 4.1.4.1 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.5 Gastric Cancer 4.1.5.1 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.6 Melanoma 4.1.6.1 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 4.1.7 Others (HIV, Thalassemia) 4.1.7.1 Global Other Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) Chapter 5 Companion Diagnostics Market, by Geography, 2011 - 2019 (USD Million) 5.1 Overview 5.1.1 Comparative Analysis: Global Companion Diagnostics Market by Geography, 2012 & 2019 (Value %) 5.2 North America 5.2.1 North America Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.3 Europe 5.3.1 Europe Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.4 Asia-Pacific 5.4.1 Asia-Pacific Companion Diagnostics Market, Size and Forecast, 2011 - 2019 (USD Million) 5.5 Rest of the World (RoW) 5.5.1 RoW Companion Diagnostics Market, Size and Forecast 2011 - 2019 (USD Million) Chapter 6 Competitive Landscape 6.1 Market Share by Key Players, 2012 (%) Chapter 7 Recommendations 5 Transparency Market Research

  6. Breast Pumps Market 7.1 Adoption of newer business models enabling co-developing companion diagnostics 7.2 Focus on research-intense investments Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.1.5.1 FDA Approval 8.2 Agendia N.V. 8.2.1 Company Overview 8.2.2 Product Portfolio 8.2.3 Business Strategies 8.2.4 Recent Developments 8.3 Agilent Technologies, Inc. 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 BioGenex Laboratories Inc. 8.4.1 Company Overview 8.4.2 Product Portfolio 8.4.3 Business Strategies 8.4.4 Recent Developments 8.5 bioMérieux SA 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 6 Transparency Market Research

  7. Breast Pumps Market 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 GE Healthcare Ltd. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Genomic Health, Inc. 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Life Technologies Corporation 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Qiagen N.V. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Resonance Health Analysis Services Pty Ltd. 8.10.1 Company Overview 8.10.2 Product Portfolio 8.10.3 Business Strategies 8.10.4 Recent Developments 7 Transparency Market Research

  8. Breast Pumps Market 8.11 Roche Holdings AG 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.11.5 Recent Developments 8.12 Siemens Healthcare 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments About Us Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ 8 Transparency Market Research

More Related